Search JFSF

JFSF Vol 7, No 4, December 2022, p.257

doi: 10.22540/JFSF-07-257



Corrigendum to: Sarcopenia in Hemiplegia

Maria C. Papadatou1,2

  1. National Center of Rehabilitation, Athens, Greece
  2. National Kapodistrian University of Athens, Laboratory Research of Musculoskeletal Disorders, Greece


The author regrets the originally published manuscript Sarcopenia in Hemiplegia, JFSF Vol 5, No 2, June 2020, p.38-41, contained an error in the “Therapeutic approach and management” section. Specifically, instead of selective androgen receptor modulators (SARMs), mistakenly it is written selective estrogen receptor modulators (SERMs).

This article corrects the following

Sarcopenia in Hemiplegia, JFSF, Vol 5, No 2, June 2020, p.38-41

Share this article on:
Twitter  LinkedIn  Facebook